RAP
Click for more information
0.00% 20.5¢ resapp health limited

A new Beginning..., page-3411

  1. RNClarke
    1,432 Posts.
    lightbulb Created with Sketch. 859
    clock Created with Sketch.
    19/11/19
    10:34
    Post #: 41501404
    HeraMed's product is nothing revolutionary, doppler based foetal monitors already exist and have been approved in the past.

    ResApp's diagnostic product for children is a very different approval process.

    The Global Head of Diagnostics for Roche ($380B Market Cap) Tim Jaeger believes the digital transformation will drive better clinical decisions and diagnosis. They would be all over ResApp.

    RAP Price at posting: 28.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 29  Upvote
    lightbulb Created with Sketch. 3  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EVN Evolution shares up 3% on quarterly results for June showing rise in gold production
right-arrow Created with Sketch.
MEU Marmota hopes to punch through the ceiling of a high-grade system at Goolagong – geology willing
right-arrow Created with Sketch.
SKC SkyCity to lose NZ$5M in 2025 over complaint closedown
right-arrow Created with Sketch.
IVR Investigator Resources hits 8m @ 1.06% copper on-site Stuart Shelf JV project acreage
right-arrow Created with Sketch.
ENR Encounter sniffs 4% niobium across 1.6km of strike in WA
right-arrow Created with Sketch.
NEWS Talking the US election, the spectre of Trump and what's hot on the ASX200: Wealth Within
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.